ROCHE FARMACEUTICA E QUIMICA, LDA. secures contract for Ocrelizumab 920 Mg/23 Ml Sol Inj Fr 23 Ml Sc

Portugal, Sept. 29 -- Portugal based ROCHE FARMACEUTICA E QUIMICA, LDA. has secured contract from Unidade Local De Saude De Almada-Seixal, E.P.E. for Ocrelizumab 920 Mg/23 Ml Sol Inj Fr 23 Ml Sc. The value of the contract is worth 53864.82 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....